Impact of corticotropin-releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in normal controls and patients with irritable bowel syndrome

Gut

Volumn 42, Issue 6, 1998, Pages 845-849

  Fukudo, S ^a,b   Nomura, T ^a   Hongo, M ^b  

^a Department of Psychosomatic Medicine ^*

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adrenocorticotropic hormone; Colonic motility; Corticotropin releasing factor; Duodenal motility; Irritable bowel syndrome

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; VASOPRESSIN;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; HORMONE ACTION; HUMAN; INTESTINE MOTILITY; INTESTINE PRESSURE; IRRITABLE COLON; MALE; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

EID: 0031807954     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.42.6.845     Document Type: Article

References (41)

1. Malagelada J-R. The gastroduodenal response to stress in man in health and functional dyspepsia. In: Tache Y, Wingate D, eds. Brain-gut interactions. Boca Raton, Florida: CRC Press, 1991:297-305.
2. Drossman DA, Richter JE, Talley NJ, et al. The functional gastrointestinal disorders. Boston: Little, Brown and Co., 1994.
3. Fukudo S, Suzuki J. Colonic motility, autonomic function, and gastrointestinal hormones under psychological stress on irritable bowel syndrome. Tohoku J Exp Med 1987;151: 373-85.
4. Fukudo S, Nomura T, Muranaka M, et al. Brain-gut response to stress and cholinergic stimulation in irritable bowel syndrome. J Clin Gastroenterol 1993;16:133-41.
5. Williams CL, Villar RG, Peterson JM, et al. Stress-induced changes in intestinal transit in the rat: a model for irritable bowel syndrome. Gastroenterology 1988;94:611-21.
6. Lenz HJ, Raedler A, Greten H, et al. Stress-induced gastrointestinal secretory and motor responses in rats are mediated by endogenous cortocotropin-releasing factor. Gastroenterology 1988;95:1510-17.
7. Gue M, Junien JL, Bueno L. Conditioned emotional response in rats enhances colonic motility through the central release of corticotropin-releasing factor. Gastroenterology 1991;100:964-70.
8. Monnikes H, Schmidt BG, Tache Y. Psychological stress-induced accelerated colonic transit in rats involves hypothalamic corticotropin-releasing factor. Gastroenterology 1993;104:716-23.
9. Williams CL, Peterson JM, Villar RG, et al. Corticotropin-releasing factor directly mediates colonic responses to stress. Am J Physiol 1987;253:G582-6.
10. Dunn AJ, Berridge CW. Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses? Brain Res Rev 1990;15:71-100.
11. Holsboer F, von Bardeleben U, Steiger A. Effects of intravenous corticotropin-releasing hormone upon sleep-related growth hormone surge and sleep EEG in men. Neuroendocrinology 1988;48:32-8.
12. Thompson WG, Creed F, Drossman DA, et al. Functional bowel disease and functional abdominal pain. Gastroenterol Int 1992;5:75-91.
13. Agreus L, Svardsudd K, Nyren O, et al. Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology 1995;109: 671-80.
14. Lemann M, Flourie B, Picon L, et al. Motor activity recorded in the unprepared colon of healthy humans. Gut 1995;37:649-53.
15. Suda T, Tomori N, Yajima F, et al. Immunoreactive corticotropin-releasing factor in human plasma. J Clin Invest 1985;76:2026-9.
16. Hermus ARMM, Pieters GFFM, Willemsen JJ, et al. Hypotensive effects of ovine and human corticotrophin-relcasing factors in man. Eur J Clin Pharmacol 1987;31:531-4.
17. Bazzocchi G, Ellis J, Villanueva-Meyer J, et al. Postprandial colonic transit and motor activity in chronic constipation. Gastroenterology 1990;98:686-93.
18. Kellow JE, Gill RC, Wingate DL. Prolonged ambulant recordings of small bowel motility demonstrate abnormality in the irritable bowel syndrome. Gastroenterology 1990;98:1208-18.
19. Kellow JE, Phillips SF. Altered small bowel motility in irritable bowel syndrome is correlated with symptoms. Gastroenterology 1987;92:1885-93.
20. Stanghellini V, Camilleri M, Malagelada J-R. Chronic idiopathic intestinal pseudo-obstruction: clinical and intestinal manometric findings. Gut 1987;28:5-12.
21. Vale W, Spiess J, Rivier C, et al. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and β endorphin. Science 1981;213:1394-7.
22. Petrusz P, Merchenthaler I. The corticotropin-releasing factor system. In: Nemeroff CB, ed. Neuroendocrinology. Boca Raton, Florida: CRC Press, 1992:129-83.
23. Owens MJ, Nemeroff CB. Physiology and pharmacology of corticotropin-releasing factor. Pharmacol Rev 1991;43: 425-73.
24. 2β receptor mRNAs are differentially distributed between the rat central nervous system and peripheral tissues. Life Sci 1997;60:857-64.
25. Iwakiri Y, Chijiiwa Y, Motomura Y, et al. Presence of functional receptors for corticotropin-releasing hormone in caecal circular smooth muscle cells of guinea pig. Life Sci 1997;60:857-64.
26. Martins JM, Kastin AJ, Banks WA. Unidirectional specific and modulated brain to blood transport of corticotropin-releasing hormone. Neuroendocrinology 1996;63:338-48.
27. Perrin MH, Donaldson CJ, Chen R, et al. Cloning and functional expression of a rat brain corticotropin-releasing factor (CRF) receptor. Endocrinology 1993;133:3058-61.
28. Bueno L, Fargeas MJ, Gue M, et al. Effects of corticotropin-releasing factor on plasma motilin and somatostatin levels and gastrointestinal motility in dogs. Gastroenterology 1986; 91:884-9.
29. Mayer EA, Sytnik B, Reddy SN, et al. Corticotropin-releasing factor (CRF) increases post-prandial duodenal motor activity in humans. Neurogastroenterol Motil 1992;4: 53-60.
30. Tizabi Y, Aguilera G. Desensitization of the hypothalamic-pituitary-adrenal axis following prolonged administration of corticotropin-releasing hormone or vasopressin. Neuroendocrinology 1992;56:611-18.
31. Young EA, Akil H. Corticotropin-releasing factor stimulation of adrenocorticotropin and β-endorphin release: effects of acute and chronic stress. Endocrinology 1985;117: 23-30.
32. van Dijken, de Goeji DCE, Sutanto W, et al. Short inescapable stress produces long-lasting changes in the brain-pituitary-adrenal axis of adult male rats. Neuroendocrinology 1993;58:57-64.
33. Kovacs K, Makara GB. Factors from the paraventricular nucleus mediate inhibitory effect of alpha-2-adrenergic drugs on ACTH secretion. Neuroendocrinology 1993;57: 346-50.
34. Dinan TG, Barry S, Ahkion S, et al. Assessment of central noradrenergic functioning in irritable bowel syndrome using a neuroendocrine challenge test. J Psychosom Res 1990;34:575-80.
35. Behan DP, De Souza EB, Lowry PJ, et al. Corticotropin-releasing factor (CRF) binding protein: a novel regulator of CRF and related peptides. Front Neuroendocrinol 1995;16: 362-82.
36. Nemeroff CB. New vistas in neuropeptide research in neuropsychiatry: focus on corticotropin-releasing factor. Neuropsychopharmacology 1992;6:69-75.
37. Elam M, Thoren P, Srensson TH. Locus ceruleus neurons and sympathetic nerves: activation by visceral afferents. Brain Res 1986;375:117-25.
38. Mayer EA Raybould HE. Role of visceral afferent mechanisms in functional bowel disorders. Gastroenterology 1990;99:1688-704.
39. Tache Y, Monnikes H, Bonaz B, et al. Role of CRF in stress-related alterations of gastric and colonic motor function. Ann N Y Acad Sci 1993;697:233-13.
40. Lembo T, Plourde V, Shui Z, et al. Effects of the corticotropin-releasing factor (CRF) on rectal afferent nerves in humans. Neurogastroenterol Motil 1996;8:9-18.
41. Kumar D, Thompson PD, Wingate DL, et al. Abnormal REM sleep in the irritable bowel syndrome. Gastroenterology 1992;103:12-17.